Tosedostat (CHR-2797)
Jump to navigation
Jump to search
Preliminary Results
Phase II
- Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S Advani, Anthony Charman, Richard Spruyt, Martin Toal, Hagop Kantarjian, Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study, The Lancet Oncology, Volume 14, Issue 4, April 2013, Pages 354-362, ISSN 1470-2045, 10.1016/S1470-2045(13)70037-8.